HCW Biologics News - August 19, 2026

🟢 HCW Biologics rises 5.2% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results

With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...

🟢 HCW Biologics is trading 15.63% up in pre-market — no clear catalyst identified

HCW Biologics is trading 15.63% up at $2.46 after no clear August 19, 2026 company-specific catalyst was identified. - The latest major disclosure was the...